Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2025-11-24 00:00:00 ET · period of report 2025-11-20 · accession 0001238303-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-24 | 2025-11-20 | REGN | LAROSA JOSEPH J | EVP GC, Secret | F - Tax | $736.77 | -12.7K | 22.8K | -36% | -$9.35M |
| D | 2025-11-24 | 2025-11-20 | REGN | LAROSA JOSEPH J | EVP GC, Secret | M - OptEx | $555.67 | +14.4K | 35.5K | +69% | +$8.03M |
| D | 2025-11-24 | 2025-11-20 | REGN | LAROSA JOSEPH J | EVP GC, Secret | M - OptEx | $0.00 | -14.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-20 | F | D | 12,686 | $736.77 | 22,839 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-20 | M | A | 14,450 | $555.67 | 35,525 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-11-20 | M | D | 14,450 | $0.00 | 0 | D | $555.67 · — to 2025-12-16 | 14,450 Common Stock | (F1) The stock option award vested in four equal annual installments, commencing one year after the date of grant. |